Evidence map›Paper›PMID 37153142›Full record

ArticleFrontiers in cellular and infection microbiology2023

Evaluating the effect of SARS-CoV-2 spike mutations with a linear doubly robust learner.

Xin Wang, Mingda Hu, Bo Liu, Huifang Xu, Yuan Jin, Boqian Wang, Yunxiang Zhao, Jun Wu, Junjie Yue, Hongguang Ren

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xin WangBeijing Institute of Biotechnology, State Key Laboratory of Pathogen and Biosecurity, Beijing, China.
Mingda HuBeijing Institute of Biotechnology, State Key Laboratory of Pathogen and Biosecurity, Beijing, China.
Bo LiuBeijing Institute of Biotechnology, State Key Laboratory of Pathogen and Biosecurity, Beijing, China.
Huifang XuBeijing Institute of Biotechnology, State Key Laboratory of Pathogen and Biosecurity, Beijing, China.
Yuan JinBeijing Institute of Biotechnology, State Key Laboratory of Pathogen and Biosecurity, Beijing, China.
Boqian WangBeijing Institute of Biotechnology, State Key Laboratory of Pathogen and Biosecurity, Beijing, China.
Yunxiang ZhaoBeijing Institute of Biotechnology, State Key Laboratory of Pathogen and Biosecurity, Beijing, China.
Jun WuBeijing Institute of Biotechnology, State Key Laboratory of Pathogen and Biosecurity, Beijing, China.
Junjie YueBeijing Institute of Biotechnology, State Key Laboratory of Pathogen and Biosecurity, Beijing, China.
Hongguang RenBeijing Institute of Biotechnology, State Key Laboratory of Pathogen and Biosecurity, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Driven by various mutations on the viral Spike protein, diverse variants of SARS-CoV-2 have emerged and prevailed repeatedly, significantly prolonging the pandemic. This phenomenon necessitates the identification of key Spike mutations for fitness enhancement. To address the need, this manuscript formulates a well-defined framework of causal inference methods for evaluating and identifying key Spike mutations to the viral fitness of SARS-CoV-2. In the context of large-scale genomes of SARS-CoV-2, it estimates the statistical contribution of mutations to viral fitness across lineages and therefore identifies important mutations. Further, identified key mutations are validated by computational methods to possess functional effects, including Spike stability, receptor-binding affinity, and potential for immune escape. Based on the effect score of each mutation, individual key fitness-enhancing mutations such as D614G and T478K are identified and studied. From individual mutations to protein domains, this paper recognizes key protein regions on the Spike protein, including the receptor-binding domain and the N-terminal domain. This research even makes further efforts to investigate viral fitness

Indexed as

SARS-CoV-2Spike Glycoprotein, CoronavirusMutationSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2basic reproduction number (R0)causal inferencefitnessmutationSARS-CoV-2

Identifiers

PMID37153142
PMCPMC10154619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.